Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-24

Clinical Trial Update: HEARTS R34 Feasibility Study, Autistic Participants [NA]

View source ↗

Summary

The HEARTS R34 feasibility trial in autistic participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston University Charles River Campus | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED